Salesforce
CRM
Oracle
ORCL
Microsoft
MSFT
4
Tesla
TSLA
5
Adobe
ADBE
US Stock MarketDetailed Quotes
STRO Sutro Biopharma
- 0.8306
- -0.0694-7.71%
Trading Apr 24 10:30 ET
69.58MMarket Cap-0.28P/E (TTM)
0.8880High0.8000Low404.33KVolume0.8822Open0.9000Pre Close341.62KTurnover0.57%Turnover RatioLossP/E (Static)83.78MShares5.170052wk High1.56P/B58.81MFloat Cap0.523152wk Low--Dividend TTM70.81MShs Float28.3000Historical High--Div YieldTTM9.78%Amplitude0.5231Historical Low0.8440Avg Price1Lot Size
Sutro Biopharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -71.61%-191.54M | -609.79%-71.74M | -92.57%-64.52M | 130.31%9.46M | -6.15%-64.74M | -3,245.00%-111.62M | 158.97%14.07M | -150.87%-33.5M | -879.13%-31.2M | -73.00%-60.99M |
| Net income from continuing operations | -112.99%-227.46M | -333.20%-72.44M | 1.01%-48.79M | -24.64%-48.02M | -16.31%-58.21M | 10.41%-106.79M | 189.80%31.07M | -152.89%-49.28M | -48.10%-38.52M | -27.97%-50.05M |
| Operating gains losses | ---32.14M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 5.90%7.22M | 7.91%1.87M | 3.45%1.8M | 3.41%1.79M | 9.04%1.76M | 19.79%6.82M | 13.29%1.73M | 20.93%1.74M | 23.91%1.73M | 21.70%1.62M |
| Other non cash items | 119.82%36.97M | 34.49%10.2M | 27.21%9.4M | 617.39%8.79M | 1,268.47%8.59M | 475.63%16.82M | 835.93%7.58M | 854.26%7.39M | 125.18%1.23M | -20.91%628K |
| Change In working capital | 125.89%8.9M | 27.09%-15.74M | -290.27%-7.12M | 514.23%48.37M | 31.93%-16.62M | -132.92%-34.38M | -210.30%-21.58M | -95.32%3.74M | -21.92%7.88M | -367.38%-24.41M |
| -Change in receivables | 194.84%27.46M | 89.92%-1.96M | 104.45%295K | 19,425.40%24.35M | 273.68%4.78M | -642.15%-28.96M | -571.20%-19.45M | -107.67%-6.63M | 99.85%-126K | -458.20%-2.75M |
| -Change in prepaid assets | -10,703.67%-11.56M | -935.72%-6.93M | -393.20%-2.55M | -95.83%306K | 67.81%-2.39M | 103.08%109K | -10.95%-669K | 130.35%868K | 2,603.07%7.33M | -3,601.89%-7.42M |
| -Change in payables and accrued expense | -122.08%-6.65M | -86.37%3.38M | -127.88%-1.35M | -323.37%-6.01M | -20.95%-2.66M | 464.21%30.11M | 476.77%24.78M | 658.59%4.84M | -19.30%2.69M | -54.13%-2.2M |
| -Change in other current liabilities | -40.02%-6.42M | -16.80%-1.71M | -16.88%-1.66M | -79.23%-1.55M | -79.57%-1.5M | -341.57%-4.59M | -398.78%-1.46M | -396.25%-1.42M | -280.71%-862K | -285.59%-837K |
| -Change in other working capital | 119.53%6.06M | 65.64%-8.51M | -130.55%-1.86M | 2,788.99%31.27M | -32.51%-14.84M | -132.56%-31.06M | -320.14%-24.78M | 289.68%6.08M | -101.26%-1.16M | -114.27%-11.2M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -71.61%-191.54M | -609.79%-71.74M | -92.57%-64.52M | 130.31%9.46M | -6.15%-64.74M | -3,245.00%-111.62M | 158.97%14.07M | -150.87%-33.5M | -879.13%-31.2M | -73.00%-60.99M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 5,668.50%218.51M | 472.08%87.49M | 229.18%147.29M | -221.49%-80.38M | -4.96%64.11M | 88.80%-3.92M | 37.93%-23.51M | -46.11%-114.02M | 38.07%66.16M | 104.51%67.45M |
| Net PPE purchase and sale | 28.20%-3.1M | 25.88%-1.07M | -152.44%-828K | 52.87%-756K | 52.65%-446K | 45.09%-4.32M | 57.20%-1.44M | 55.56%-328K | 27.09%-1.6M | 39.34%-942K |
| Net investment purchase and sale | 56,576.73%221.61M | 501.21%88.56M | 230.28%148.12M | -217.50%-79.62M | -5.62%64.55M | 101.44%391K | 36.07%-22.07M | -47.08%-113.69M | 35.21%67.76M | 98.04%68.39M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 5,668.50%218.51M | 472.08%87.49M | 229.18%147.29M | -221.49%-80.38M | -4.96%64.11M | 88.80%-3.92M | 37.93%-23.51M | -46.11%-114.02M | 38.07%66.16M | 104.51%67.45M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -31.62%94.05M | 99.23%-24K | 117.72%1.02M | -29.91%96.49M | -139.15%-3.43M | 184.71%137.55M | -125.57%-3.13M | -119.23%-5.74M | 2,409.77%137.66M | 1,052.37%8.76M |
| Net issuance payments of debt | 67.34%-4.08M | --0 | --0 | --0 | -30.66%-4.08M | -33.33%-12.5M | 0.00%-3.13M | 0.00%-3.13M | 0.00%-3.13M | ---3.13M |
| Net common stock issuance | 706.34%96.53M | --0 | --0 | 9,110.59%96.53M | --0 | -78.73%11.97M | --0 | --0 | -87.81%1.05M | --10.92M |
| Proceeds from stock option exercised by employees | -10.40%2.12M | --0 | 14.36%1.09M | --0 | -27.14%1.03M | 25.73%2.37M | --0 | 37.86%954K | --0 | 18.97%1.41M |
| Net other financing activities | -100.38%-509K | ---24K | 97.93%-74K | -100.03%-37K | 17.07%-374K | 29,412.74%135.72M | --0 | -7,038.00%-3.57M | 1,074,807.69%139.74M | -5.87%-451K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -31.62%94.05M | 99.23%-24K | 117.72%1.02M | -29.91%96.49M | -139.15%-3.43M | 184.71%137.55M | -125.57%-3.13M | -119.23%-5.74M | 2,409.77%137.66M | 1,052.37%8.76M |
| Net cash flow | ||||||||||
| Beginning cash position | 45.74%70.14M | 112.12%175.44M | -61.16%91.65M | 4.31%66.08M | 45.74%70.14M | 53.83%48.13M | -15.30%82.71M | 195.01%235.97M | 112.76%63.34M | 53.83%48.13M |
| Current changes in cash | 449.75%121.02M | 225.15%15.73M | 154.67%83.79M | -85.19%25.57M | -126.71%-4.07M | 30.72%22.01M | 74.63%-12.57M | -967.65%-153.26M | 243.77%172.62M | 1,105.82%15.22M |
| End cash Position | 172.54%191.16M | 172.54%191.16M | 112.12%175.44M | -61.16%91.65M | 4.31%66.08M | 45.74%70.14M | 45.74%70.14M | -15.30%82.71M | 195.01%235.97M | 112.76%63.34M |
| Free cash flow | -67.89%-194.64M | -676.41%-72.81M | -93.15%-65.34M | 126.52%8.7M | -5.25%-65.19M | -2,590.44%-115.93M | 146.38%12.63M | -151.95%-33.83M | -508.97%-32.8M | -68.26%-61.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025